Filana Therapeutics (FLNA) Assets Average (2011 - 2026)
Filana Therapeutics (FLNA) posted quarterly Assets Average of $106.1 million for Q2 2026, down 23.18% year-over-year from $138.2 million in Q2 2025, and down 6.37% quarter-over-quarter from $113.4 million in Q1 2026.
Filana Therapeutics (FLNA) Assets Average (2011 - 2026) Analysis & Trends
Filana Therapeutics' Assets Average history runs 16 years deep, the most recent figure standing at $106.1 million for Q2 2026.
- In Q2 2026, Assets Average fell 23.18% year-over-year to $106.1 million; the TTM figure through Jun 2026 stood at $106.1 million (down 23.18% YoY), while the FY2025 annual figure was $137.9 million, down 10.77% from the prior year.
- Assets Average for Q2 2026 stood at $106.1 million, down from $113.4 million in the prior quarter.
- The five-year high for Assets Average was $255.5 million in Q1 2022, with the low at $106.1 million in Q2 2026.
- The 5-year median for Assets Average is $187.8 million (2023), against an average of $180.7 million.
- The sharpest annual moves came in 2022 and 2025: Assets Average jumped 35.05% in 2022, then tumbled 43.27% in 2025.
- Filana Therapeutics' Assets Average stood at $221.1 million in 2022, then declined by 26.67% to $162.1 million in 2023, then advanced by 17.61% to $190.6 million in 2024, then slumped by 34.93% to $124.0 million in 2025, then dropped by 14.44% to $106.1 million in 2026.
- Business Quant data shows FLNA's Assets Average at $106.1 million in Q2 2026, $113.4 million in Q1 2026, and $124.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | 106.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.14 Mn |
| Mar 31, 2026 | 113.36 Mn |
| Dec 31, 2025 | 124.04 Mn |
| Sep 30, 2025 | 132.56 Mn |
| Jun 30, 2025 | 138.16 Mn |
| Mar 31, 2025 | 149.23 Mn |
| Dec 31, 2024 | 190.64 Mn |
| Sep 30, 2024 | 233.66 Mn |
| Jun 30, 2024 | 199.64 Mn |
| Mar 31, 2024 | 153.69 Mn |
| Dec 31, 2023 | 162.10 Mn |
| Sep 30, 2023 | 184.89 Mn |
| Jun 30, 2023 | 207.68 Mn |
| Mar 31, 2023 | 226.47 Mn |
| Dec 31, 2022 | 221.06 Mn |
| Sep 30, 2022 | 217.33 Mn |
| Jun 30, 2022 | 235.79 Mn |
| Mar 31, 2022 | 255.49 Mn |
| Dec 31, 2021 | 270.52 Mn |
| Sep 30, 2021 | 277.78 Mn |